Deborah Dunsire Ultragenyx Pharmaceutical Inc. (RARE) insider trading activity

RARE Quotes by TradingView

Deborah Dunsire is of Ultragenyx Pharmaceutical Inc.. Currently has a direct ownership of 30,815 shares of RARE, which is worth approximately $814,748. The most recent transaction as insider was on May 15, 2025, when has been sold 5,740 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.8K
22.89% 3M change
22.89% 12M change
Total Value Held $814,748

Deborah Dunsire Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 15 2025
BUY
Grant, award, or other acquisition
-
5,740 Added 15.7%
30,815 Common Stock
Jun 18 2024
BUY
Grant, award, or other acquisition
-
5,345 Added 17.57%
25,075 Common Stock
Jun 07 2023
BUY
Grant, award, or other acquisition
-
3,860 Added 16.36%
19,730 Common Stock
Jun 24 2022
BUY
Grant, award, or other acquisition
-
3,300 Added 17.21%
15,870 Common Stock
Jun 24 2021
BUY
Grant, award, or other acquisition
-
2,145 Added 14.58%
12,570 Common Stock

Also insider at

ALXN
ALEXION PHARMACEUTICALS, INC.
Director
SYRS
Syros Pharmaceuticals, Inc. Healthcare
MCK
MCKESSON CORP Healthcare
Director
DD

Deborah Dunsire

Cambridge, MA

Track Institutional and Insider Activities on RARE

Follow Ultragenyx Pharmaceutical Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RARE shares.

Notify only if

Insider Trading

Get notified when an Ultragenyx Pharmaceutical Inc. insider buys or sells RARE shares.

Notify only if

News

Receive news related to Ultragenyx Pharmaceutical Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RARE